Since July 25 of this year, the collective cultivation of medicinal cannabis and the production of its derivatives are legal in Peru after the government authorities decreed the rule approved by the Congress that was requested several times by patients and relatives. This means that they will be able to cultivate the cannabis plant and produce its derivatives for medicinal use in organisations with members registered in the National Registry of Cannabis Patients.
In this sense, the request for the collective self-cultivation of cannabis was presented to the Congress by the Cannabis association “Gotas de Esperanza” and the Federation of Medicinal Cannabis. Likewise, the licenses will be granted by the Ministry of Health, while the Anti-Drug Directorate of the National Police of Peru will be in charge of carrying out a security procedure to ensure the physical intangibility of cannabis for medicinal use.
Despite the fact that medical cannabis and its derivatives were legalized in 2017, the possibility of free access remained complicated for many patients because there were few pharmacies that commercialized it. In this sense, the activist and journalist Francesca Brivio, is the founder of “Gotas de Esperanza” and was a key factor and insistent figure for this law to be carried out, since she persevered in demanding the interim president of Peru Francisco Sagasi to execute this rule before retiring from the presidency.
Cannabis-based medicine has been of great help to Brivio in alleviating the symptoms of three diseases: mastocytosis, Raynaud’s syndrome and Ehler Danlos syndrome. Something that conventional medicine had never achieved.